Dinorah Friedmann‐Morvinski

5.0k total citations · 1 hit paper
49 papers, 3.9k citations indexed

About

Dinorah Friedmann‐Morvinski is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Dinorah Friedmann‐Morvinski has authored 49 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Genetics and 15 papers in Immunology. Recurrent topics in Dinorah Friedmann‐Morvinski's work include Glioma Diagnosis and Treatment (15 papers), RNA Interference and Gene Delivery (5 papers) and Cancer Cells and Metastasis (5 papers). Dinorah Friedmann‐Morvinski is often cited by papers focused on Glioma Diagnosis and Treatment (15 papers), RNA Interference and Gene Delivery (5 papers) and Cancer Cells and Metastasis (5 papers). Dinorah Friedmann‐Morvinski collaborates with scholars based in Israel, United States and Russia. Dinorah Friedmann‐Morvinski's co-authors include Inder M. Verma, Yasushi Soda, Tomotoshi Marumoto, Oded Singer, Mark H. Ellisman, Eric A. Bushong, Eugene Ke, Lilach Agemy, Erkki Ruoslahti and Venkata Ramana Kotamraju and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Dinorah Friedmann‐Morvinski

47 papers receiving 3.9k citations

Hit Papers

CRISPR-Cas9 genome editing using targeted lipid nanoparti... 2020 2026 2022 2024 2020 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
    2020 430 citations Daniel Rosenblum, Anna Gutkin et al. Science Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dinorah Friedmann‐Morvinski Israel 27 2.2k 972 924 762 569 49 3.9k
Alexander H. Stegh United States 29 3.3k 1.5× 1.4k 1.4× 957 1.0× 1.1k 1.5× 439 0.8× 42 5.0k
Shawn Hingtgen United States 25 2.1k 0.9× 918 0.9× 564 0.6× 792 1.0× 863 1.5× 69 3.4k
Ilya V. Ulasov United States 35 2.3k 1.0× 540 0.6× 1.5k 1.6× 623 0.8× 779 1.4× 112 4.4k
Michele Cilli Italy 37 2.0k 0.9× 658 0.7× 933 1.0× 259 0.3× 439 0.8× 108 4.0k
Brenda Auffinger United States 24 992 0.4× 403 0.4× 621 0.7× 698 0.9× 598 1.1× 38 2.6k
John M. Heddleston United States 27 1.8k 0.8× 1.2k 1.2× 1.5k 1.6× 935 1.2× 570 1.0× 43 4.2k
Yu Han United States 28 987 0.4× 392 0.4× 1.1k 1.2× 759 1.0× 686 1.2× 55 3.2k
Laura Cerchia Italy 34 2.5k 1.1× 695 0.7× 577 0.6× 201 0.3× 523 0.9× 96 3.3k
William P. J. Leenders Netherlands 40 2.2k 1.0× 1.2k 1.3× 839 0.9× 1.1k 1.4× 366 0.6× 119 4.2k
Irina V. Balyasnikova United States 36 1.9k 0.8× 311 0.3× 1.4k 1.5× 798 1.0× 915 1.6× 113 4.2k

Countries citing papers authored by Dinorah Friedmann‐Morvinski

Since Specialization
Citations

This map shows the geographic impact of Dinorah Friedmann‐Morvinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dinorah Friedmann‐Morvinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dinorah Friedmann‐Morvinski more than expected).

Fields of papers citing papers by Dinorah Friedmann‐Morvinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dinorah Friedmann‐Morvinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dinorah Friedmann‐Morvinski. The network helps show where Dinorah Friedmann‐Morvinski may publish in the future.

Co-authorship network of co-authors of Dinorah Friedmann‐Morvinski

This figure shows the co-authorship network connecting the top 25 collaborators of Dinorah Friedmann‐Morvinski. A scholar is included among the top collaborators of Dinorah Friedmann‐Morvinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dinorah Friedmann‐Morvinski. Dinorah Friedmann‐Morvinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shapira, Guy, et al.. (2025). Cell-of-origin-specific behavioral deficits in oligodendrocyte-derived glioblastoma. Cell Reports. 44(8). 116043–116043.
2.
Ad‐El, Nitay, Meir Goldsmith, Anna Gutkin, et al.. (2025). Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma. Journal of Controlled Release. 385. 114018–114018. 4 indexed citations
3.
Furth, Noa, Avishay Spitzer, Tomer‐Meir Salame, et al.. (2024). Oncogenic IDH1 mut drives robust loss of histone acetylation and increases chromatin heterogeneity. Proceedings of the National Academy of Sciences. 122(1). e2403862122–e2403862122. 2 indexed citations
4.
Friedmann‐Morvinski, Dinorah, et al.. (2023). Drivers of heterogeneity in the glioblastoma immune microenvironment. Current Opinion in Cell Biology. 85. 102279–102279. 5 indexed citations
5.
Friedmann‐Morvinski, Dinorah & Dolores Hambardzumyan. (2023). Monocyte-neutrophil entanglement in glioblastoma. Journal of Clinical Investigation. 133(1). 45 indexed citations
6.
Friedmann‐Morvinski, Dinorah, et al.. (2022). Isolation and characterization of the immune cell fraction from murine brain tumor microenvironment. STAR Protocols. 3(1). 101106–101106. 2 indexed citations
7.
Rousso-Noori, Liat, Tova Waks, Anat Globerson Levin, et al.. (2021). P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas. Nature Communications. 12(1). 3615–3615. 31 indexed citations
8.
Yeini, Eilam, Paula Ofek, Sabina Pozzi, et al.. (2021). P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression. Nature Communications. 12(1). 1912–1912. 56 indexed citations
9.
Rousso-Noori, Liat, et al.. (2021). Exploring the longitudinal glioma microenvironment landscape uncovers reprogrammed pro-tumorigenic neutrophils in the bone marrow. Cell Reports. 36(5). 109480–109480. 42 indexed citations
10.
Rosenblum, Daniel, Anna Gutkin, Ranit Kedmi, et al.. (2020). CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy. Science Advances. 6(47). 430 indexed citations breakdown →
11.
Säälik, Pille, Prakash Lingasamy, Liat Rousso-Noori, et al.. (2019). Peptide-guided nanoparticles for glioblastoma targeting. Journal of Controlled Release. 308. 109–118. 79 indexed citations
12.
Mazor, Rafi, Dinorah Friedmann‐Morvinski, Tom Alsaigh, et al.. (2018). Cleavage of the leptin receptor by matrix metalloproteinase–2 promotes leptin resistance and obesity in mice. Science Translational Medicine. 10(455). 54 indexed citations
13.
Hirbe, Angela C., Sonika Dahiya, Dinorah Friedmann‐Morvinski, et al.. (2016). Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation. Digital Commons@Becker (Washington University School of Medicine). 4 indexed citations
14.
Ben‐Gedalya, Tziona, Lorna Moll, Michal Bejerano‐Sagie, et al.. (2015). Alzheimer's disease‐causing proline substitutions lead to presenilin 1 aggregation and malfunction. The EMBO Journal. 34(22). 2820–2839. 26 indexed citations
15.
Friedmann‐Morvinski, Dinorah, Vipul Bhargava, Soham Gupta, Inder M. Verma, & Shankar Subramaniam. (2015). Identification of therapeutic targets for glioblastoma by network analysis. Oncogene. 35(5). 608–620. 18 indexed citations
16.
Friedmann‐Morvinski, Dinorah, Eric A. Bushong, Eugene Ke, et al.. (2012). Dedifferentiation of Neurons and Astrocytes by Oncogenes Can Induce Gliomas in Mice. Science. 338(6110). 1080–1084. 421 indexed citations
17.
Padler‐Karavani, Vered, Nancy Hurtado‐Ziola, Minya Pu, et al.. (2011). Human Xeno-Autoantibodies against a Non-Human Sialic Acid Serve as Novel Serum Biomarkers and Immunotherapeutics in Cancer. Cancer Research. 71(9). 3352–3363. 112 indexed citations
18.
Agemy, Lilach, Dinorah Friedmann‐Morvinski, Venkata Ramana Kotamraju, et al.. (2011). Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proceedings of the National Academy of Sciences. 108(42). 17450–17455. 300 indexed citations
19.
Ramaswamy, Suvasini, Balaram Thota, Sridevi Vijay Shinde, et al.. (2011). Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2. Journal of Biological Chemistry. 286(29). 25882–25890. 133 indexed citations
20.
Harrus, Shimon, et al.. (2003). Down-regulation of MHC class II receptors of DH82 cells, following infection with Ehrlichia canis. Veterinary Immunology and Immunopathology. 96(3-4). 239–243. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander H. Stegh Breakdown of academic impact, for papers by Shawn Hingtgen Breakdown of academic impact, for papers by Ilya V. Ulasov Breakdown of academic impact, for papers by Michele Cilli Breakdown of academic impact, for papers by Brenda Auffinger Breakdown of academic impact, for papers by John M. Heddleston Breakdown of academic impact, for papers by Yu Han Breakdown of academic impact, for papers by Laura Cerchia Breakdown of academic impact, for papers by William P. J. Leenders Breakdown of academic impact, for papers by Irina V. Balyasnikova
Rankless by CCL
2026